NCT02033109View on ClinicalTrials.gov

Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
HIV
Interventions
DRUG

PC-1005

Intravaginal use

DRUG

HEC gel

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

Population Council

OTHER

NCT02033109 - Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use | Biotech Hunter | Biotech Hunter